Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with ...

Trastuzumab appears to improve outcomes in patients with BM secondary to controlling extra-CNS disease, which remains the main cause of cancer-related mortality. The single-agent lapatinib has a ...

A total of 104 patients were enrolled, of whom 53 received DV and 50 received Lapatinib plus Capecitabine. All patients had previously been treated with Trastuzumab and Taxanes. As of data cutoff date ...

We are working with Guy’s and St. Thomas’ NHS Foundation Trust to produce national standardised SACT regimen-specific consent forms. We want to support clinicians in ensuring all patients are fully ...

Giredestrant is a new type of hormone treatment. It blocks the hormone oestrogen. Pertuzumab and trastuzumab are usual treatments for breast cancer that has tested positive for HER2. The combination ...

Monoclonal antibodies (mAbs) targeting receptors of the Epidermal Growth Factor Receptor (EGFR) family, including anti-EGFR cetuximab and panitumumab and anti-ErbB2 trastuzumab and pertuzumab, are ...